These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Inactivation of cefazolin, cephaloridine, and cephalothin by methicillin-sensitive and methicillin-resistant strains of Staphylococcus aureus. Regamey C; Libke RD; Engelking ER; Clarke JT; Kirby MM J Infect Dis; 1975 Mar; 131(3):291-4. PubMed ID: 1039311 [TBL] [Abstract][Full Text] [Related]
24. [Cephalosporins from the clinical viewpoint]. Regamey C Int J Clin Pharmacol Biopharm; 1975 Mar; 11(2):93-102. PubMed ID: 1095504 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of cephalosporin antibiotics. Brogard JM; Comte F; Pinget M Antibiot Chemother (1971); 1978; 25():123-62. PubMed ID: 352251 [No Abstract] [Full Text] [Related]
26. The comparative performance of beta-lactam antibiotics against ampicillin sensitive Escherichia coli in conditions simulating those of the infected urinary bladder. Greenwood D; O'Grady F Br J Exp Pathol; 1974 Jun; 55(3):245-50. PubMed ID: 4607731 [TBL] [Abstract][Full Text] [Related]
27. In-vitro susceptibility of Mycobacterium fortuitum and related strains to cephalosporins. Haas H; Michel J; Sacks TG J Med Microbiol; 1973 May; 6(2):141-5. PubMed ID: 4488467 [No Abstract] [Full Text] [Related]
28. Pharmacokinetics of cephalosporins in patients with normal or reduced renal function. Andriole VT J Infect Dis; 1978 May; 137 Suppl():S88-S99. PubMed ID: 349098 [TBL] [Abstract][Full Text] [Related]
29. Response of ampicillin resistant Escherichia coli to cephalosporins in an in vitro model simulating conditions of bacterial growth in the urinary bladder. Greenwood D; O'Grady F Br J Exp Pathol; 1975 Apr; 56(2):167-71. PubMed ID: 1106751 [TBL] [Abstract][Full Text] [Related]
30. [Effectiveness of cephalosporins in experimental anaerobic gas infection]. Poliak MS Antibiotiki; 1974 Aug; 19(8):733-6. PubMed ID: 4375943 [No Abstract] [Full Text] [Related]
31. The penetration characteristics of cefazolin, cephalothin, and cephradine into bone in patients undergoing total hip replacement. Cunha BA; Gossling HR; Pasternak HS; Nightingale CH; Quintiliani R J Bone Joint Surg Am; 1977 Oct; 59(7):856-9. PubMed ID: 908715 [TBL] [Abstract][Full Text] [Related]
32. Studies on protein binding of cefazolin and other antibiotics. Shimizu T Jpn J Antibiot; 1974 Jun; 27(3):296-301. PubMed ID: 4474418 [No Abstract] [Full Text] [Related]
33. The cephalosporins: activity and clinical use. Weinstein AJ Drugs; 1980 Aug; 20(2):137-54. PubMed ID: 6995096 [TBL] [Abstract][Full Text] [Related]
34. In vitro activity of BL-S217, a new cephalosporin antibiotic. Casey F; Bodey GP J Antibiot (Tokyo); 1974 Jul; 27(7):520-4. PubMed ID: 4156357 [No Abstract] [Full Text] [Related]
35. Antibiotics in cement. Moore B J Bone Joint Surg Br; 1977 May; 59(2):139-42. PubMed ID: 873973 [No Abstract] [Full Text] [Related]
36. In vitro studies with Ciba 36278-Ba, a new cephalosporin derivative. Russell AD Microbios; 1972 Dec; 6(24):221-30. PubMed ID: 4487949 [No Abstract] [Full Text] [Related]
37. [In vitro activity of 4 cephalosporins on gram-negative bacteria and Staphylococcus aureus of hospital origin]. Herrera N; Silva J; Godoy J; Urdanivia R; Becerra S; Jofre M Rev Med Chil; 1985 Apr; 113(4):329-33. PubMed ID: 3835642 [No Abstract] [Full Text] [Related]
38. Comparative activity of ampicillin and seven cephalosporins against group D streptococci. Hamilton-Miller JM J Clin Pathol; 1974 Oct; 27(10):828-31. PubMed ID: 4214839 [TBL] [Abstract][Full Text] [Related]
39. [Study on the dynamics of antimicrobial agents in vivo--cephaloridine and cephalothin]. Kitamoto O; Fukaya K; Wajima T J Antibiot B; 1965 Dec; 18(6):443-6. PubMed ID: 5296407 [No Abstract] [Full Text] [Related]
40. Cefazolin vs cephalothin and cephaloridine. A comparison of their clinical pharmacology. Regamey C; Gordon RC; Kirby WM Arch Intern Med; 1974 Mar; 133(3):407-10. PubMed ID: 4811478 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]